13
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61160 | Antiparasitic agent-2 | ||
Antiparasitic agent-2 (compound 8a) 对 L. infantum 和 T. cruzi 展示出较高的抗寄生效力,其 IC50 值分别为 7.28 μM 和 2.30 μM。同时,Antiparasitic agent-2 对 HepG2 癌细胞亦表现出一定的细胞毒性,CC50 值为 26.79 μM。 | |||
T60519 |
Antiparasitic agent-4
|
||
Antiparasitic agent-4 (compound 4q) 具有高抗寄生虫活性,其对于婴儿利什曼原虫 (L. infantum)的 IC50值为 8.51 μM,对克氏锥虫 (T. cruzi)的IC50值为2.20 μM。Antiparasitic agent-4 对癌细胞 HepG2 也具有细胞毒性,CC50值为 18.97 μM。 | |||
T61245 |
Antiparasitic agent-7
|
||
Antiparasitic agent-7 (compound 5d) displays specific antiparasitic activity against Leishmania infantum (L. infantum), exhibiting an IC50 value of 2.85 μM. Additionally, Antiparasitic agent-7 demonstrates cytotoxicity against HepG2 cells with a CC50 value of 10.61 μM [1]. | |||
T83025 | Antiparasitic agent-19 | ||
Antiparasitic agent-19 (compound 40) 是一种化合物,具备广泛的抗寄生虫活性,且对布氏锥虫、婴儿利什曼原虫和克氏锥虫具有较低的毒性。 | |||
T79415 | Antiparasitic agent-18 | Parasite | Microbiology/Virology |
Antiparasitic agent-18 (compound 3a) 对T. brucei (EC50=0.4 μM)、T. cruzi (EC50=0.21 μM) 和 L. donovani (EC50=0.26 μM) 表现出高度的活性和选择性,证明其为一种有效的抗原虫化合物。 | |||
T74773 | Antiparasitic agent-14 | ||
Antiparasitic agent-14 是一种抗寄生虫剂,具备细胞毒性和抗寄生虫活性,能够抑制锥体鞭毛体和无鞭毛体的生长。 | |||
T61001 |
Antiparasitic agent-6
|
||
Antiparasitic agent-6 (compound 5b) 对婴儿利什曼原虫表现出选择性抗寄生活性 (IC50 = 3.89 μM)。Antiparasitic agent-6 还对 HepG2 细胞表现出一定的细胞毒性,CC50值为 13.64 μM。 | |||
T61641 |
Antiparasitic agent-5
|
||
Antiparasitic agent-5 (compound 8h) exhibits potent selectivity as an antiparasitic agent against Leishmania infantum (L. infantum), with an IC50 value of 2.50 μM. Additionally, this compound displays cytotoxic effects on HepG2 cells with a CC50 value of 6.78 μM [1]. | |||
T61221 |
Antiparasitic agent-8
|
||
Antiparasitic agent-8 (Compound 9) exhibits potent antiparasitic activity against Hymenolepis nana, while demonstrating low levels of cytotoxicity [1]. | |||
T61683 |
Antiparasitic agent-9
|
||
Antiparasitic agent-9 (compound 47) is a highly active and orally administered antiparasitic agent, exhibiting potent antiparasitic efficacy against the human parasite [1]. | |||
T61538 |
Antiparasitic agent-10
|
||
Antiparasitic agent-10 (Compound 94) is a potent anti-parasitic agent specifically designed to target and combat parasitic infections. It demonstrates notable anti-schistosomal activity, particularly against adults of Schistosoma mansoni. As a result, this compound holds significant potential for utilization in Schistosomiasis research as a viable treatment option [1]. | |||
T83024 | Antiparasitic agent-20 | Parasite | Microbiology/Virology |
Antiparasitic agent-20 (Compound 1p) 是一种抗寄生虫剂,对T. brucei和T. cruzi展现出显著效力,其EC50值分别为0.09 μM和14.1 μM,表现出其广泛的抗寄生虫活性。 | |||
T78966 |
Antiparasitic agent-17
|
Parasite | Microbiology/Virology |
Antiparasitic agent-17(化合物 5u)为口服有效的抗寄生虫药物,针对氯喹敏感菌株 (Pf3D7) 与氯喹耐药菌株 (PfK1) 表现出抑制作用,其IC50分别为0.96 μM及1.67 μM。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN4893 |
Rapanone
拉帕酮,2,5-Dihydroxy-3-tridecyl-[1,4]benzoquinone,2,5-Dihydroxy-3-tridecylcyclohexa-2,5-diene-1,4-dione,酸藤子醌 |
Apoptosis; Phospholipase; Antibacterial; Parasite | Apoptosis; Metabolism; Microbiology/Virology |
Rapanone (2,5-Dihydroxy-3-tridecyl-[1,4]benzoquinone) 是一种具有广泛生物活性的天然苯醌,如抗肿瘤、抗氧化、抗炎、抗菌和抗寄生虫活性。它还是选择性人滑膜 PLA2抑制剂,IC50值为 2.6 μM。 |